Oxford BioDynamics Plc (LON:OBD – Get Free Report)’s share price was up 39% during trading on Wednesday . The company traded as high as GBX 0.70 ($0.01) and last traded at GBX 0.70 ($0.01). Approximately 95,053,336 shares traded hands during trading, an increase of 900% from the average daily volume of 9,501,976 shares. The stock had previously closed at GBX 0.50 ($0.01).
Oxford BioDynamics Price Performance
The company has a current ratio of 0.68, a quick ratio of 2.80 and a debt-to-equity ratio of 370.22. The company has a market cap of £1.86 million, a price-to-earnings ratio of -9.95 and a beta of 0.42. The company’s 50 day moving average price is GBX 1.05 and its 200 day moving average price is GBX 3.02.
Oxford BioDynamics Company Profile
Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.
In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.
Read More
- Five stocks we like better than Oxford BioDynamics
- 3 Fintech Stocks With Good 2021 Prospects
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- What Is WallStreetBets and What Stocks Are They Targeting?
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
